SCHEMBL31386975

C[C@@H](O)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O

nearest known ligand 0.63

Predicted protein targets (top 8)

	gene	UniProt	supporting neighbours	confidence
▸	CALCR	P30988	4/20	0.63

▸	C5AR1	P21730	2/20	0.60

▸	NPY2R	P49146	7/20	0.58

▸	NPY4R	P50391	7/20	0.58

▸	NPY5R	Q15761	7/20	0.58

▸	NPY1R	P25929	5/20	0.58

▸	KDM1A	O60341	2/20	0.57

▸	F2	P00734	1/20	0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30523581	0.99	CALCR (0.63)	CALCRC5AR1NPY2RNPY4RNPY5R
SCHEMBL29647453	0.96	C5AR1 (0.62)	CALCRC5AR1NPY2RNPY4RNPY5R
SCHEMBL30148163	0.96	C5AR1 (0.62)	CALCRC5AR1NPY2RNPY4RNPY5R
SCHEMBL30523596	0.96	C5AR1 (0.62)	CALCRC5AR1NPY2RNPY4RNPY5R
SCHEMBL29637925	0.96	C5AR1 (0.63)	CALCRC5AR1NPY2RNPY4RNPY5R
SCHEMBL29637944	0.94	C5AR1 (0.65)	CALCRC5AR1NPY2RNPY4RNPY5R
SCHEMBL31386983	0.92	C5AR1 (0.58)	CALCRC5AR1NPY2RNPY4RNPY5R
SCHEMBL30432183	0.90	F2 (0.59)	CALCRNPY2RNPY4RNPY5RNPY1R
SCHEMBL29695646	0.88	NPY2R (0.63)	CALCRC5AR1NPY2RNPY4RNPY5R
SCHEMBL29525286	0.88	NPY2R (0.68)	CALCRNPY2RNPY4RNPY5RNPY1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
WO-2025037315-A1	DENDRITIC CELLS-TARGETED NANOPARTICLES FOR T CELL ACTIVATION AND CANCER IMMUNOTHERAPY	B.G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD. (IL)	2025-02-20	—	—	WO	claimed
WO-2025037315-A1	DENDRITIC CELLS-TARGETED NANOPARTICLES FOR T CELL ACTIVATION AND CANCER IMMUNOTHERAPY	B.G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD. (IL)	2025-02-20	—	—	WO	disclosed